Solid Tumors
AMXT1501-103: Phase 1b/2 Trial Investigating the Safety and Efficacy of Oral AMXT 1501 and Oral DFMO in Combination with Standard of Care in Patients with Advanced Solid Tumors who Progressed after Prior Therapies
- Details
ClinicalTrials.gov ID:
NCT07287917
Diagnosis Type:
NA
USOR Number:
- Address
,
P: